India has reported in recent weeks a sharp upsurge in Covid-19 cases, which has forced authorities to institute new lockdowns and urged health authorities to increase the pace of vaccination across the country, and at the same time, stop deliveries to customers, including Morocco.
With some 53 million out of 1.3 billion inhabitants vaccinated to date, local media denounce a serious delay, estimating that the world’s largest vaccine manufacturer will struggle to meet the goal of vaccinating 300 million people by the end of July.
In this sense, the Serum Institute of India (SII), the largest vaccine manufacturer in the world in terms of volume, had recently asked foreign governments to be patient while waiting for their supply of anti-Covid vaccines. 19.
He claimed to have been “charged with prioritizing the needs of India”.
On the other hand, the Gavi Vaccine Alliance announced on Thursday that the delivery of anti-Covid vaccines to disadvantaged countries via the Covax system will be delayed, due to the lack of an export license from India which faces a increased local demand.
These delays in the granting of new export licenses “are due to the increased demand for vaccines” in India, which is confronted with the delay of vaccinations and the rise in contaminations, underlined a spokesperson for Gavi who co- pilots the Covax system with the World Health Organization (WHO) and the Coalition for Innovations in Epidemic Preparedness (Cepi).
In addition to providing 200 million doses to the COVAX system this year, India is also expected to manufacture one billion doses of Covid-19 vaccines with US and Japanese funding for the benefit of the new “Quad Vaccine Partnership” by the end. from 2022.
In addition, India has so far supplied more than 60 million doses of mainly Covishield vaccine to 76 countries, including Morocco.